Mouse Anti-MEOX1 Recombinant Antibody (CBFYM-2067) (CBMAB-M2248-FY)

Zeng, G., Liu, X., Su, X., Wang, Y., Liu, B., Zhou, H., ... & Li, F. (2023). The role of MEOX1 in non-neoplastic and neoplastic diseases. Biomedicine & Pharmacotherapy, 158, 114068.

Baßler, K., Schmidleithner, L., Shakiba, M. H., Elmzzahi, T., Köhne, M., Floess, S., ... & Beyer, M. (2023). Identification of the novel FOXP3-dependent Treg cell transcription factor MEOX1 by high-dimensional analysis of human CD4+ T cells. Frontiers in Immunology, 14.

Xiao, X., Rui, B., Rui, H., Ju, M., & Hongtao, L. (2022). MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell‐cycle checkpoint gene CCNB1. Environmental Toxicology, 37(3), 504-513.

Yatagai, Y., Oshima, H., Sakamoto, T., Shigemasa, R., Kitazawa, H., Hyodo, K., ... & Hizawa, N. (2021). Expression quantitative trait loci for ETV4 and MEOX1 are associated with adult asthma in Japanese populations. Scientific Reports, 11(1), 18791.

Schumacher, D., Peisker, F., & Kramann, R. (2021). MEOX1: a novel druggable target that orchestrates the activation of fibroblasts in cardiac fibrosis. Signal Transduction and Targeted Therapy, 6(1), 440.

Wu, Y., Li, Y. J., Shi, L. L., Liu, Y., Wang, Y., Bao, X., ... & Zhang, J. X. (2021). Spatio-temporal model of Meox1 expression control involvement of Sca-1-positive stem cells in neointima formation through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4. Stem Cell Research & Therapy, 12(1), 1-15.

Wang, W., Fang, Q., Zhang, Z., Wang, D., Wu, L., & Wang, Y. (2020). PPARα ameliorates doxorubicin-induced cardiotoxicity by reducing mitochondria-dependent apoptosis via regulating MEOX1. Frontiers in Pharmacology, 11, 528267.

Gasparyan, M., Lo, M. C., Jiang, H., Lin, C. C., & Sun, D. (2020). Combined p53-and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer. Journal of Biological Chemistry, 295(34), 12188-12202.

Sun, L., Yuan, H., Burnett, J., Gasparyan, M., Zhang, Y., Zhang, F., ... & Sun, D. (2019). MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer. International Journal of Medical Sciences, 16(1), 68.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols